Legislature(2011 - 2012)BELTZ 105 (TSBldg)
02/23/2012 01:30 PM Senate LABOR & COMMERCE
| Audio | Topic |
|---|---|
| Start | |
| SB175 | |
| SB122 | |
| SB25 | |
| SB174 | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| += | SB 25 | TELECONFERENCED | |
| += | SB 175 | TELECONFERENCED | |
| += | SB 122 | TELECONFERENCED | |
| += | SB 174 | TELECONFERENCED | |
| += | SB 116 | TELECONFERENCED | |
| *+ | SB 190 | TELECONFERENCED | |
| + | HB 168 | TELECONFERENCED | |
| += | SB 138 | TELECONFERENCED | |
| += | SB 157 | TELECONFERENCED | |
SB 175-PRACTICE OF NATUROPATHY
1:34:24 PM
CHAIR EGAN announced consideration of SB 175 and said that some
committee members had questions. [CSSB 175(L&C), 27-LS1230\B,
was before the committee.]
DON HABEGAR, Director, Division of Corporations, Business and
Professional Licensing, in the Department of Commerce, Community
and Economic Development (DCCED), introduced himself.
SENATOR PASKVAN asked Mr. Habegar to review the department's
position on the recent restrictions put upon naturopaths that no
one could identify the origin of and explain why nothing had
been done.
MR. HABEGAR replied that he had done a lot of digging in trying
find the mileposts on this issue and found that the department
has had a consistent interpretation of the statutes and
regulations about it: one was that naturopaths don't have
prescriptive authority.
He found several complaints over the last 18 years during which
naturopaths have been practicing. The first was dismissed
because of lack of evidence. The second one brought the issue to
the forefront and ended up with a consent agreement. The
division has maintained that naturopaths don't have prescriptive
authority, and that was the issue in this particular case. As it
unfolded, pharmacies started asking the department about what
prescriptive authority means and said they weren't supplying
legend drugs to naturopaths. That is what led to the discussion
before them today and the question of what the division is going
to do.
If legislation is not passed to correct the situation, he said
the division is in a position to go out with regulations to
clear up what is confusing language to all. Those regulations
won't go out until after going through the process. How they
proceed past that is yet undetermined.
SENATOR PASKVAN asked him to precisely state, assuming
legislation didn't pass, whether the regulations will be drafted
allowing the practice that has existed over the last 18 years or
not.
MR. HABEGAR replied that because the division has interpreted
statute to mean that no prescriptive authority has been granted
by the legislature, regulations will be developed to comport to
that.
SENATOR PASKVAN said he understood that anecdotal issues have
arisen - one a consent decree and the other dismissed - but it
begs the issue that directors have let a practice exist for 18
years without doing anything. He was troubled about why all of a
sudden they decided to do a 180 degree turn in terms of its
application, whatever the interpretation is.
1:40:24 PM
MR. HABEGAR said he recognized that there have been numerous
interpretations and that some pharmacists have prescribed in
response to written prescriptions, and if legislation is not
passed, they would give the issue careful consideration. He
believes it is important for regulations to support statute and
not confuse licensees.
SENATOR PASKVAN asked if he is supporting the legislation's
passage to remove any uncertainty about interpretation.
MR. HABEGAR replied yes, but SB 175 needs more clarity. For
instance, hydro-therapy means the use of water in all forms. Is
that the physical state of water that is deemed a liquid or is
it hydrotherapy with all its various components, i.e. saline
solution? And clarifying this language would help the division
immensely.
1:43:07 PM
CHAIR EGAN said this is the fourth meeting on this bill and the
department should have offered an amendment a couple of meetings
ago if it had issues. Testimony the committee has received
indicates that this legislation clarifies what has been done for
18 years; it isn't changing anything.
MR. HABEGAR responded that he had a fiscal note and part of it
was about getting a group of professionals together and help
them to hammer out the details. The mix of professionals wasn't
specified, but certainly MDs should be part of the process and
someone from the Board of Pharmacy.
SENATOR DAVIS asked if he truly understands what SB 175 does.
For 18 years naturopaths had the authority to prescribe
medicines from pharmacies and all of a sudden something happened
to take that authority away and the director just told them the
division plans to write regulations in support of that. So this
legislation won't do anything.
MR. HABEGAR responded that he thinks SB 175 takes regulation
that was supporting their interpretation of statute, which was
no prescriptive authority, and adds that prescriptive authority.
There is room for clarification through the regulatory process
and he would do that with the help of experts.
1:46:13 PM
SENATOR MENARD joined the committee.
SENATOR DAVIS asked if he had shared his idea of clarity with
anyone, because they had been working on this bill for a long
time; he had even testified on it. Now today when they are
getting ready to move it, he is saying it needs more
clarification and doesn't have anything to suggest.
MR. HABEGAR apologized for being remiss in addressing the
committee's concerns, but it is an ongoing process.
1:47:28 PM
SENATOR GIESSEL said her concern and the concern of her
colleagues is that a professional license with its accompanying
scope of practice is a property right and it sounds like the
division has plans to arbitrarily change it. Even if they do
pass this bill some tweaking will be done to it.
Another of her concerns was the $127,000 fiscal note for travel
expenses for two naturopath prescription drug task force
meetings that she didn't think would be needed. Another concern
she had was the task force consists of naturopaths, the medical
board, the pharmacy board and the division personnel, but this
scope of practice applies to naturopaths only, not the other two
professions. She was also concerned about the $36,000 fiscal
note each month for filling 100 Medicaid prescriptions. She
didn't think this bill needed a fiscal note.
MR. HABEGAR replied that the fiscal note isn't from his
department; it came from HSS. The $16,000 fiscal note was in
response to the original bill, and if it needs to be changed as
results of changes to the bill he would withdraw it.
CHAIR EGAN thanked him and announced other people on line who
could also answer fiscal note questions.
1:50:43 PM
DR. WARD HURLBURT, Director of the Division of Public Health,
and Chief Medical Officer for the Department of Health and
Social Services (DHSS), Anchorage, Alaska, said he understood
that clarification was needed and the language in this version
of SB 175 would expand the naturopathic scope of practice and
the fiscal note was based on the cost associated with expanding
that prescriptive practice. For instance, the manufacturer of
capsicum, a tincture of cayenne pepper that is used medicinally,
made it a prescription item. In allopathic medicine, if you ask
someone to take ibuprofen or Advil, the over-the-counter form is
200 milligrams and very few insurance policies would cover that.
Whereas a physician could prescribe an 800 milligram tablet and
it would likely be covered.
The bill's language notes that the prescriptive authority is for
drugs that are derived from natural substances and his recent
research and experience indicated that 25-50 percent of
pharmaceutical agents requiring a prescription are derived from
natural substances. That is the reason for the concern that it
would expand the scope and therefore expand the cost of health
care for items that are not now covered by insurance.
1:53:14 PM
SENATOR GIESSEL asked what the prescriptive cost to Medicaid has
been under existing regulations for the last 18 years.
DR. HURLBURT said he didn't have that information, but would get
it.
SENATOR GIESSEL said she was not interested in speculating about
expansion, but was only asking about practices for the past 18
years.
1:54:10 PM
SENATOR PASKVAN asked if he ever protested what the naturopaths
were doing in the last 18 years - even one time, because someone
is protesting now, and he was wondering what it was about.
DR. HURLBURT said he had been in his current position for 2.5
years and during that time he hadn't protested what naturopathic
doctors had been doing.
1:55:08 PM
CHAIR EGAN asked Dr. Hurlburt if any other chief medical
officers had protested naturopathic practices in the last 18
years.
DR. HURLBURT replied that he didn't know but would find out.
1:55:46 PM
JON SHERWOOD, Medicaid Special Projects, Medicaid and Health
Care Policy, Department of Health and Social Services (DHSS),
said Medicaid has two fiscal notes and that this issue has
stayed beneath their radar. He understood that naturopaths do
not have prescriptive authority and they are not included in the
Medicaid program, and since he doesn't pay them, they have not
had to enroll in the Medicaid program. Changes to Medicaid under
the Affordable Care Act require that any prescriber that
Medicaid is paying for a prescription needs to enroll in the
program so that their provider number can be captured. A one-
time cost for creating a way for them to enroll in the program
and $36,000 a year for 100 prescriptions per month was
estimated. But he emphasized that was only an estimate and that
a wide variety of medicines are prescribed, and it would help to
have a clearer understanding of what substances they would be
talking about.
SENATOR DAVIS asked him to explain the two fiscal notes.
MR. SHERWOOD explained that the Medicaid Assistance
Administration has a one-time cost of $75,000, $18,800 of which
would come from general funds; the other one is $36,000 per year
for health care Medicaid services and that is 50 percent
federal, 50 percent state general funds. The $16,000 fiscal note
is from the Department of Commerce, Community and Economic
Development (DCCED).
2:00:02 PM
SENATOR GIESSEL asked Dr. Jasper if naturopaths have national
provider identifier (NPI) numbers.
DR. JASPER answered yes.
SENATOR GIESSEL asked if they are reimbursed by insurance
companies.
DR. JASPER answered yes; Alaska statute provides for that
coverage in its group health policies.
SENATOR GIESSEL asked if any Alaska naturopaths have enrolled in
Medicaid or are Medicare providers.
DR. JASPER replied that naturopaths are not eligible to enroll.
Eligibility for Medicare is determined by federal laws, and the
eligibility for Medicaid is determined by state law; neither has
authorized naturopathic doctors to participate in Medicare or
Medicaid.
2:01:29 PM
DR. JASPER also added that hydrotherapy is the application of
hot and cold water packs to the body and shouldn't result in any
prescription expenses; it's not IV water or saline injections.
Maybe it would help Mr. Habegar to have that clarified.
2:02:32 PM
SENATOR PASKVAN moved to report CSSB 175(L&C), version B, from
committee with individual recommendations and attached fiscal
note(s) although he hoped the fiscal note would be removed.
There were no objections, and it was so ordered.
SB 175-PRACTICE OF NATUROPATHY
2:30:35 PM
CHAIR EGAN reconvened the meeting and returned attention to SB
175.
SENATOR PASKVAN moved to rescind the committee's previous action
to report SB 175 out of committee and restated the motion as
follows: to report CSSB 175(L&C), version \B from committee with
a restated Labor and Commerce fiscal note of zero with
individual recommendations. There were no objections and it was
so ordered.
| Document Name | Date/Time | Subjects |
|---|---|---|
| SB 125 lttr supporting, AADA.pdf |
SL&C 2/23/2012 1:30:00 PM |
SB 125 |
| SB 125 Purpose of bill.PDF |
SL&C 2/23/2012 1:30:00 PM |
SB 125 |
| SB 125 Sectional Analysis - 2-3-12.pdf |
SL&C 2/23/2012 1:30:00 PM |
SB 125 |
| SB 125 Sponsor Statement.PDF |
SL&C 2/23/2012 1:30:00 PM |
SB 125 |
| SB 25 lttr supporting, AGC.pdf |
SL&C 2/23/2012 1:30:00 PM |
SB 25 |
| SB 25 lttr supporting, ARCTEC 021512.pdf |
SL&C 2/23/2012 1:30:00 PM |
SB 25 |
| SB 25 lttr supporting, MEA 021512.pdf |
SL&C 2/23/2012 1:30:00 PM |
SB 25 |
| SB 25 lttr supporting, RDC corrected 021712.pdf |
SL&C 2/23/2012 1:30:00 PM |
SB 25 |
| SB025-DCCED-AIDEA-02-10-12 (A).pdf |
SL&C 2/23/2012 1:30:00 PM |
SB 25 |
| SB025-DCCED-AIDEA-02-10-12 (B).pdf |
SL&C 2/23/2012 1:30:00 PM |
SB 25 |
| SB 25 ASSETS version E.PDF |
SL&C 2/23/2012 1:30:00 PM |
SB 25 |
| SB 25 lttr supporting, AIPPA 021612.pdf |
SL&C 2/23/2012 1:30:00 PM |
SB 25 |
| SB 175 CS L&C v B DRAFT.PDF |
SL&C 2/23/2012 1:30:00 PM |
SB 175 |
| SB 116 lttr opposing, ANC Muni Risk Mgt..pdf |
SL&C 2/23/2012 1:30:00 PM |
SB 116 |
| SB 116 lttr opposing, ABC 022212.PDF |
SL&C 2/23/2012 1:30:00 PM |
SB 116 |